Form D · Other Technology
Invoq Health, Inc.
Mundelein, IL · CIK 0001808311
Offering snapshot reported Jul 30, 2026 · SEC filing
- Reported sold
- $58.8M Offering amount: $71.4M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 30, 2026 | Initial | $58,811,822 | No comparison | 15 | SEC filing |
| Apr 22, 2022 | Initial | $25,899,995 | No comparison | 4 | SEC filing |
| Sep 21, 2021 | Initial | $14,066,495 | No comparison | Not reported | SEC filing |
| Apr 2, 2020 | Initial | $1,501,500 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592715
$21,374,980 is for SAFE conversions
Source: Form D, filed Jul 30, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Burka | Director |
| Mayank Kadhuja | Director |
| Mayank Kale | Director, Executive |
| Ryan Singh | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
3871 Melody St.
Mundelein, IL, 60060
Mundelein, IL, 60060